Use access key #2 to skip to page content.
$7.98 0.08 (1.01%)
9/5/2008 4:00 PM

AMERICAN ORIENTL BIO (AOB)

CAPS Rating:
****

The Company, together with its wholly owned subsidiaries, is a pharmaceutical and Traditional Chinese Medicine company which develops, manufactures and commercializes both plant-based pharmaceutical and plant-based nutraceutical products.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating AOB

Add Stock to Watchlist

What the Community Thinks

Total Members

1745 Outperforms
57 Underperforms
 

All-Stars

391 Outperforms
21 Underperforms
 

Wall Street

4 Outperforms
1 Underperforms
 

Members bullish on AOB are also bullish on:

Members bearish on AOB are also bearish on:

Ticker Tags

Biotechnology (294), Drug Manufacturers - Major (27), Small Cap (1922), Nutraceuticals (1), China (199)
Suggest a tag

AMERICAN ORIENTL BIO At A Glance

Current Price: $7.98
Last Trade Time: 9/5/2008 4:00 PM
Open: $7.87
Previous Close: $7.90
Daily Range: $7.75 - $8.01
52-Week Range: $7.29 - $14.48
Volume: 1,254,663
Market Cap: $618.17M
P/E Ratio: 11.79
Compare Our Special Broker Offers!

Stock Trends

AOB VS S&P 500 (SPY)

AOB 12 month chart vs. S&P

News & Discussion Boards

Top Bull Pitch

Recs

11

AMERICAN ORIENTL BIO (AOB)

Avatar tuffsledding (99.91) Submitted: 5/13/08 10:47 PM

Expect volatility, but if Chinese pharmaceutical usage begins to rise from its current very low level (compared to western countries), this company will reap huge benefits. With the growth of Chinese economy, rapid increase in disposable income and the desire to adopt western ways, this could be a r...More

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

10

AMERICAN ORIENTL BIO (AOB)

Avatar bsb2182 (< 20) Submitted: 6/03/08 11:04 AM

Sorry, but I've had enough of AOB's management playing share dilution games. I sat through the one last year, but I'm not doing it again. I had serious criticisms of last year's unjustified dilution and the announced $75M buyback, and this new $125M dilution is the last straw.

As was the case with...More

Replies: 4 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 266 :   1 2 3 4 5 Next » Jump to page:

Recs

0

 (AOB)

Avatar InternetSecurity (64.22) Submitted: 9/05/08 3:50 PM : Outperform Start Price: $7.98 AOB Score: 0.30

American Oriental Bioengineering is on someone's watch list :) ... and guess what, it won't be just the Chinese lining the pockets of such companies, it will also be me and everyone I speak to. I've never been a health nut (like my mom) and consider myself more on the scientific side than the anecdotal. But anecdotally - Pe Min Gan Wan that my accupuncturist gave me for allergies - makes me feel GOOD - no other side effects - and worked immediately against the allergies. By contrast, the Western drug company solution to allergies that we all know the brand name of - I hate with a passion - it gives me terrible crashes when it is wearing off and twitching and an inability to think clearly. Accupuncturist? you say - yes - and again nothing I ever imagined myself doing - but it WORKS - on a very tough problem that Western medicine offered me only very ugly options for.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

 (AOB)

Avatar jasoha (< 20) Submitted: 8/28/08 2:27 PM : Outperform Start Price: $8.35 AOB Score: -0.37

BEST EPS PAST FIVE YEARS AND PROJECT FOR NEXT FIVE YEARS. GREAT PROFIT AND LOW DEBT.
i CAN NOT UNDERSTAND WHY THIS STOCK IS NOT MOVING, SHOULD BE ABOVE $10.00 NOW AND $16.00 BY YEAR END.

Report this Post Replies: 0 | Reply | Permalink

Recs

2

 (AOB)

Avatar juliej104 (97.06) Submitted: 8/28/08 1:04 PM : Outperform Start Price: $8.29 AOB Score: 0.39

American Oriental Bioengineering, Inc targets two markets in China:


The pharmaceutical market and the nutraceutical market.


It sells its products primarily to hospitals, clinics, pharmacies


and retail outlets at over 100,000 locations in all provinces,


including rural areas and major cities in China.


In October 2007, it completed the acquisition of


Guangxi Boke Pharmaceutical Company Limited.


Entering at 8.27(ish). One dollar above AOB's 52 wk low, hoping for nice appreciation over the next few years.


Report this Post Replies: 0 | Reply | Permalink

Recs

1

 (AOB)

Avatar CurlingCanuck (33.37) Submitted: 8/28/08 12:40 PM : Outperform Start Price: $8.25 AOB Score: 0.81

This stock is 20% below 200 day moving average. Million dollar portfolio put it on watch list today.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

 (AOB)

Avatar DaBajan (69.51) Submitted: 8/27/08 4:10 PM : Outperform Start Price: $8.23 AOB Score: 0.72

While volumes are light, I must agree with Bill on this one. Given the potential for China to boom over the next few years, small stocks like this have the opportunity to grow. It is good to get in on the bottom floor and ride the elevator to the top! Of course, should China hit civil turmoil, then all bets are off.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 266 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 5 of 5  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackJefferies 91.44 11/21/07 Outperform NS $10.65-25.07%-13.04%-12.03
TrackZacks 86.32 10/22/07 Outperform 3M $12.53-36.31%-17.35%-18.96 Toggle the visibility of 60-Second Pitch and replies
TrackLazardCapit 82.44 07/09/07 Outperform NS $9.70-17.73%-18.81%+1.08
TrackPiperJaff 81.47 07/09/07 Outperform NS $9.66-17.39%-18.76%+1.37
TrackBreanMurray 94.54 10/30/06 Outperform NS $7.04+13.35%-9.58%+22.93
TrackJimCramer 82.62 06/06/06 Underperform 3W $5.52+44.57%-2.09%-46.65

Results 1 - 5 of 5  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEB18 1906ms